Search results
Aug 16, 2023 · Community-acquired pneumonia is an acute infection of the pulmonary parenchyma in a patient who has acquired the infection in the community (as distinguished from an infection acquired in a...
- Hydrocortisone in Severe Community-Acquired Pneumonia
Background. Whether the antiinflammatory and...
- Hydrocortisone in Severe Community-Acquired Pneumonia
Oct 13, 2023 · The CDC provides clinical testing guidance for coccidioidomycosis, histoplasmosis, and blastomycosis in patients with community-acquired pneumonia. The CDC also links to other professional organizations' guidelines for diagnosis and treatment of adults and children with community-acquired pneumonia.
Apr 3, 2023 · In these international guidelines, ERS, ESICM, ESCMID and ALAT provide evidence-based clinical practice recommendations for diagnosis, empirical treatment and antibiotic therapy for sCAP, following the GRADE approach.
Background: This document provides evidence-based clinical practice guidelines on the management of adult patients with community-acquired pneumonia.
Oct 1, 2019 · This document provides clinical practice guidelines on the management of adult patients with community-acquired pneumonia, based on systematic reviews and Grading of Recommendations, Assessment, Development, and Evaluation methodology. The guidelines cover diagnostic testing, site of care, empiric antibiotic therapy, and subsequent management decisions.
In 2023, the new European guidelines on severe community-acquired pneumonia, providing clinical practice recommendations for the management of this life-threatening infection, characterized by a high burden of mortality, morbidity, and costs for the society.
Mar 21, 2023 · Background. Whether the antiinflammatory and immunomodulatory effects of glucocorticoids may decrease mortality among patients with severe community-acquired pneumonia is unclear. Methods.
